intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

As seasoned doctors exit the field, SimCare AI raises $2M to scale clinical training with AI patients

As seasoned doctors exit the field, SimCare AI raises $2M to scale clinical training with AI patients

February 27, 2025 Craig Etkin

SimCare AI, founded by two University of Chicago dropouts, has secured $2 million in seed funding to expand its AI-driven healthcare simulation platform. The company’s solution uses realistic AI patients to set a new clinical benchmark, cutting training time and cost while meeting strict accreditation standards.

Chicago, Illinois – February 27, 2025; Healthcare desperately needs more clinicians, but can’t scale up fast enough. Traditional medical training demands thousands of hours of supervised, hands-on practice and struggles to prepare today’s workforce for modern challenges – especially the management of chronic diseases. Today, SimCare AI announces $2 million in seed funding to rethink clinical training from first principles: using AI patients to bypass regulatory constraints and certify clinical skills with far fewer patient interactions.

The funding round was led by Y Combinator and Drive Capital, with participation from Harper Court Ventures Fund, Singularity Capital, Triple S Ventures, Goodwater Capital, Asymmetry Ventures, Sand Hill North, and Transpose Platform. 

The story began with a problem: when founder Vrishank Saini failed a critical clinical communications exam and couldn’t afford the $9,000 tutor fee, he got together with Tigran Bdoyan and built an AI solution instead. The tool worked so well it attracted 2,500 users and reached $5,000 in monthly recurring revenue within three weeks. After an initial rejection from Y Combinator’s S24 batch, Saini and his co-founder Bdoyan dropped out of college with no funding, moved to San Francisco, and – when told they couldn’t reapply to the same batch – created new email accounts and applied again. Y Combinator caught them but, impressed by their determination, gave them $500,000 to build SimCare AI.

“We took a risk to prove our point,” said Vrishank Saini, CEO and Co-founder of SimCare AI. “By using AI patients, we’ve set a clinical benchmark for how training should be measured – efficient, reliable, and cost-effective. Current training methods excel at teaching acute conditions but fall short with chronic diseases that develop over months and years. A medication change today might not show its impact for months, and missed interventions might not reveal their consequences for years. SimCare AI’s simulations compress these timelines dramatically, allowing clinicians to witness disease progression patterns that would traditionally take years to experience.”

The SimCare AI platform can be customized for different specialties and use cases, from residency programs preparing trainees for complex patient scenarios to social work programs practicing family interventions. Telehealth companies, for example, screen job applicants by testing their skills with SimCare AI patients, enabling faster and more cost-effective hiring. The platform also supports their onboarding, training, upskilling, and remediation without the prolonged timelines and high expenses of traditional training. For healthcare organizations, being able to benchmark and predict performance of their workforce will offer employers an advantage. Currently, SimCare AI has already closed 30 pilots with institutions including the University of Pennsylvania.

The innovation comes at a crucial moment. As seasoned physicians leave the profession while less experienced clinicians backfill positions, the clinical experience gap is widening. Traditional training methods – role-playing, in-person evaluations, and one-on-one interviews – cost institutions hundreds of thousands of dollars annually in faculty time and administrative overhead, while still failing to provide comprehensive exposure to complex patient cases.

Professor Emeritus of Medicine and Psychiatry, University of North Carolina Douglas A. Drossman MD, President at DrossmanCare commented: “I have been extremely impressed with our collaboration with SimCare AI. At DrossmanCare, in partnership with the Rome Foundation, we develop educational programs designed to enhance healthcare providers’ communication skills with patients. SimCare AI has seamlessly integrated our vast library of publications and videos on communication into an innovative program that allows providers to engage in advanced, simulated patient interviews with a virtual avatar. This approach enables providers to gain valuable insights into complex psychosocial issues through the use of sophisticated interview techniques. Additionally, the program provides real-time feedback, allowing providers to continuously refine their skills. I’ve never encountered a company with such a refined ability to replicate the nuances of a clinical encounter, offering a truly remarkable training experience.”

SimCare AI’s technology offers a radical solution: proving clinical competency with just 20 patient encounters instead of 200. The system’s sophisticated AI maps decision trees for each patient interaction, creating dynamic, realistic conversations that align with accreditation standards. This precision helps institutions track, assess, and verify student competencies according to regulatory requirements – allowing students and professionals to practice and be evaluated anytime, anywhere. This standardized approach not only reduces faculty burden and costs but accelerates the pace at which new clinicians can enter the workforce. 

Molly Bonakdarpour, Partner at Drive Capital, commented: “SimCare AI is addressing a clear need in healthcare training. In just four months, they’ve demonstrated strong early impact, delivering measurable ROI for customers. We’re impressed with their vision and execution and look forward to supporting their continued growth in AI-driven healthcare solutions.”

The platform’s impact extends across the healthcare education landscape. While medical schools use SimCare AI to teach patient interactions and clinical reasoning, therapy programs employ it for counseling practice, and telehealth companies leverage it for hiring and upskilling. SimCare AI’s precision helps institutions track, assess, and verify student competencies according to regulatory requirements – a crucial feature for medical schools, nursing programs, and continuing medical education.

Vrishank Saini added: “Looking ahead, SimCare AI plans to integrate more detailed clinical data – from transcripts to diagnostic workups – into its evaluation system. The company’s goal is to standardize clinical training and evaluation across healthcare, enabling competency to be measured quickly and reliably. For risk-bearing organizations, this provides a clear, consistent method to train clinicians in the specific skills that drive quality metrics.”

About SimCare AI

SimCare AI (YC S24) creates simulated conversations with AI patients to scale healthcare training. Healthcare organizations use our clinical simulations for more efficient recruitment, reduced training time and costs, and enhanced patient outcomes. Governments are pushing to expand the healthcare workforce by increasing training output; however, it is illegal to train without direct clinical supervision, limiting scale in training. These restrictions don’t apply to AI patients, providing a scalable solution that helps organizations train more people, meet accreditation standards, and grow faster. For more information please visit: http://simcare.ai/

About Drive Capital 

Drive Capital is a venture capital firm in Columbus that invests in world-class founders building the next generation of market-defining companies.

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.


Venture Capital
Chicago, Illinois, SimCare AI, Venture Capital

Post navigation

NEXT
MirrorTab Secures $8.5 Million to Shield Web Applications from Constantly Evolving Hacking, Bot, and Malware Threats
PREVIOUS
DiligentIQ Raises $12 Million in Series A Funding Round Led by FINTOP Capital to Accelerate AI-Powered Due Diligence in Private Markets
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Kimberly-Clark Corporation, one of the world's leading manufacturers of personal care and hygiene products, will establish an $800 million advanced manufacturing facility in Trumbull County, bringing an anticipated 491 new high-quality jobs. For Kimberly-Clark, this new facility would be its first in Ohio and represents not just a strategic expansion, but a decisive step in doubling down on growth in the American market. Spread across more than one million square feet, the Warren facility will provide the manufacturing capacity needed to unleash future growth for Kimberly-Clark’s fastest-growing personal care categories that include Baby & Child Care and Adult & Feminine Care. Warren is in geographic proximity to roughly 117 million consumers and will serve as a strategic hub for the Northeast and Midwest regions. Construction is expected to begin this month and will take up to two years.

In a statement Tamera Fenske, chief supply chain officer at Kimberly-Clark said, “Our investment in Warren is a pivotal step forward in our North America business and strategy.” “By establishing a new, state-of-the-art manufacturing facility in Ohio, we’re enhancing our ability to serve millions of consumers across the Midwest and Northeast with greater speed, agility, and resilience. It’s a once-in-a-career opportunity to build a facility from the ground up that reflects the future of manufacturing, and with the support of local partners like JobsOhio, the Department of Development, Lake to River, Western Reserve Port Authority, and local governments, we have the unique opportunity to create high-quality jobs and long-term economic impact in the region.”

Based in Dallas and employing 46,000 people in 34 countries, the company’s portfolio of brands also includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll. Its products are sold in more than 175 countries and territories.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Snorkel AI announced general availability of two new product offerings on the Snorkel AI Data Development Platform: Snorkel Evaluate and Snorkel Expert Data-as-a-Service. These launches advance its mission to turn knowledge into specialized AI—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. In addition, Snorkel AI announced it has raised $100 million in Series D funding at a $1.3 billion valuation, led by Addition. This new funding will fuel continued research and innovation in evaluating and tuning specialized AI systems with expert data.


In a statement Alex Ratner, Co-founder and CEO of Snorkel AI said, “We are seeing a surge of momentum around agentic AI, but specialized enterprise agents aren’t ready for production in most settings.” “Enterprises need domain-specific data and expertise to make this a reality. We’re excited to deliver on this need and help AI innovators develop expert data to bring their LLM and agentic systems into production with our new offerings, which round out Snorkel’s unified AI data development stack.”

Snorkel AI is building the Snorkel AI Data Development Platform for evaluating and tuning specialized AI at scale. Snorkel AI’s offerings, including Snorkel Evaluate and Snorkel Expert Data-as-a-Service, accelerate evaluation and tuning of specialized AI systems with expert data—helping teams move from prototype to production at scale by leveraging Snorkel AI’s programmatic data development technology. Launched out of the Stanford AI Lab, Snorkel AI’s platform is used in production by Fortune 500 companies, including BNY, Wayfair, and Chubb, as well as across the U.S. federal government, including the U.S. Air Force.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

TicketManager, a global leader in event ticket and guest management solutions for the corporate enterprise, today announced Valeas Capital Partners, a growth-oriented private-equity firm, has acquired a majority stake in the company. Under the terms of the agreement, Valeas is committing $110 million to support TicketManager’s strategic growth plans. TicketManager Co-Founder and CEO Tony Knopp and COO Ken Hanscom will retain a minority interest in the Company. Founded in 2007, TicketManager is the category leader in providing software and services to manage end-to-end event ticket workflow and guest experiences. Serving as the central hub and system of record for data-driven organizations, the platform streamlines every step of the ticket management process. Every year, companies spend more than $600 billion on customer entertainment, yet 43% of corporate tickets are never used and fewer than 20% of organizations leverage modern software to optimize those investments and mitigate compliance risk.

In a statement Tony Knopp, CEO and Co-Founder of TicketManager said, “Live events are an important investment for businesses of all sizes. Whether major global sponsorships, naming rights for stadiums, luxury suites or even a few season tickets for the local team, companies use them to attract and keep customers while building their brands. But in today’s market, many companies struggle with growing pressure to show the value of their ticket spending.” “We knew there was a better way, and that’s why we created TicketManager – to make company tickets easy and prove the return on investment with cutting edge technology and services.”

TicketManager is a leading event- and guest-management platform that empowers companies to make client entertainment easy and drive greater return on investment. It offers convenient and simple technology to manage corporate sports and entertainment tickets, create exceptional guest life-cycle experiences, and measure effectiveness. TicketManager is trusted by more than 500 global brands including Verizon, FedEx, Adidas, Anheuser-Busch, and Mastercard.
Load More... Subscribe

Categories

Recent Posts

  • Bespoken Spirits Announces Successful Close of Series-C Funding Round June 9, 2025
  • Bito Raises $5.7M Seed Extension to Expand AI Code Review Platform with Codebase Awareness June 9, 2025
  • Pillar Biosciences Raises $34.5M in Funding June 9, 2025
  • CloudZero Raises $56M Series C To Redefine Cloud Cost Optimization In The AI Era June 9, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.